Polymedco launches BTA stat test for detection of recurrent bladder cancer
Links shared publicly online about this topic.
- 188total visits
Polymedco launches BTA stat test for detection of recurrent bladder cancer
Polymedco, Inc. is pleased to announce the direct availability of the BTA stat® test from our sales force – The BTA stat® test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine.
View full resource at news-medical.net
Tags: Cancer, Bladder Cancer, Urinary System
Most Recently Shared on June 27, 2011 at 4:31 pm By:
Polymedco launches BTA stat test for detection of recurrent bladder cancer: Polymedco, Inc. is pleased to announ... http://bit.ly/kfTiZ4
Advertisement
